{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T14:39:30Z","timestamp":1768401570801,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"German Center for Infection Research (DZIF)"}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.ijantimicag.2016.10.013","type":"journal-article","created":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T15:16:54Z","timestamp":1480346214000},"page":"239-242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Susceptibility to cephalosporin combinations and aztreonam\/avibactam among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission"],"prefix":"10.1016","volume":"49","author":[{"given":"Alexander","family":"Mischnik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Baumert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Hamprecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Rohde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silke","family":"Peter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Feihl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Knobloch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"G\u00f6lz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Kola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"Obermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiane","family":"Querbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Willmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friedemann","family":"Gebhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelina","family":"Tacconelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Gastmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winfried V.","family":"Kern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2016.10.013_bib0010","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nrmicro2693","article-title":"Tackling antibiotic resistance","volume":"9","author":"Bush","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2016.10.013_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2016.10.013_bib0020","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/CMR.8.4.557","article-title":"\u03b2-Lactamases in laboratory and clinical resistance","volume":"8","author":"Livermore","year":"1995","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2016.10.013_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.46.1.1-11.2002","article-title":"Plasmid-determined AmpC-type \u03b2-lactamases","volume":"46","author":"Philippon","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2016.10.013_bib0030","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.diagmicrobio.2006.06.015","article-title":"Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum \u03b2-lactamase-producing Escherichia coli","volume":"56","author":"Bin","year":"2006","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2016.10.013_bib0035","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1128\/JCM.39.6.2206-2212.2001","article-title":"Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum \u03b2-lactamases: implications for the clinical microbiology laboratory","volume":"39","author":"Paterson","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2016.10.013_bib0040","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1093\/jac\/dkw216","article-title":"Colonization with third-generation cephalosporin-resistant Enterobacteriaceae on hospital admission: prevalence and risk factors","volume":"71","author":"Hamprecht","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2016.10.013_bib0045","author":"Giske"},{"key":"10.1016\/j.ijantimicag.2016.10.013_bib0050","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1128\/JCM.00404-11","article-title":"Practical approach for reliable detection of AmpC \u03b2-lactamase-producing Enterobacteriaceae","volume":"49","author":"Polsfuss","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2016.10.013_bib0055","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1128\/JCM.01856-06","article-title":"Evaluation of the Merlin MICRONAUT system for rapid direct susceptibility testing of Gram-positive cocci and Gram-negative bacilli from positive blood cultures","volume":"45","author":"Wellinghausen","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2016.10.013_bib0060","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1128\/AAC.01993-13","article-title":"Extended-spectrum-\u03b2-lactamase-producing Escherichia coli as intestinal colonizers in the German community","volume":"58","author":"Valenza","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2016.10.013_bib0065","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/cid\/ciw283","article-title":"Fecal colonization with extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae and risk factors among healthy individuals: a systematic review and metaanalysis","volume":"63","author":"Karanika","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2016.10.013_bib0070","doi-asserted-by":"crossref","first-page":"7558","DOI":"10.1128\/AAC.01477-15","article-title":"Cefepime therapy for monomicrobial Enterobacter cloacae bacteremia: unfavorable outcomes in patients infected by cefepime-susceptible dose-dependent isolates","volume":"59","author":"Lee","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2016.10.013_bib0075","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1128\/AAC.00041-14","article-title":"Unacceptably high error rates in Vitek 2 testing of cefepime susceptibility in extended-spectrum-\u03b2-lactamase-producing Escherichia coli","volume":"58","author":"Rhodes","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2016.10.013_bib0080","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ijantimicag.2010.11.028","article-title":"Strategies to overcome extended-spectrum \u03b2-lactamases (ESBLs) and AmpC \u03b2-lactamases in shigellae","volume":"37","author":"Livermore","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2016.10.013_bib0085","first-page":"545","article-title":"In vitro study to compare sensitivity of amoxicillin+clavulanic acid and cefpodoxime+clavulanic acid among \u03b2-lactamase positive clinical isolates of Gram-positive and Gram-negative pathogens","volume":"106","author":"Pal","year":"2008","journal-title":"J Indian Med Assoc"},{"key":"10.1016\/j.ijantimicag.2016.10.013_bib0090","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1128\/AAC.02841-15","article-title":"Assessment of the in vitro activity of ceftazidime\u2013avibactam against multidrug-resistant Klebsiella spp. collected in the INFORM Global Surveillance Study, 2012 to 2014","volume":"60","author":"Hackel","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2016.10.013_bib0095","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1007\/s10096-015-2498-3","article-title":"Activity of temocillin, mecillinam, ceftazidime, and ceftazidime\/avibactam against carbapenem-non-susceptible Enterobacteriaceae without carbapenemase production","volume":"34","author":"Mutters","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2016.10.013_bib0100","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1093\/jac\/dkw082","article-title":"In vitro pharmacokinetics\/pharmacodynamics of the combination of avibactam and aztreonam against MDR organisms","volume":"71","author":"Sy","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2016.10.013_bib0105","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1128\/AAC.04191-14","article-title":"In vitro susceptibility of characterized \u03b2-lactamase-producing strains tested with avibactam combinations","volume":"59","author":"Li","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2016.10.013_bib0110","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/ja.2014.45","article-title":"Antimicrobial activity of cefepime\u2013tazobactam combination tested against clinical isolates of Enterobacteriaceae","volume":"67","author":"Kaur","year":"2014","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.ijantimicag.2016.10.013_bib0115","first-page":"224","article-title":"Comparative evaluation of the in-vitro activity of six \u03b2-lactam\/\u03b2-lactamase inhibitor combinations against Gram negative bacilli","volume":"7","author":"Sood","year":"2013","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.ijantimicag.2016.10.013_bib0120","series-title":"WCK 4282 (high-dose cefepime\u2013tazobactam) against multi-resistant Gram-negative bacteria","author":"Livermore","year":"2016"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857916303491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857916303491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T21:27:34Z","timestamp":1568582854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857916303491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0924857916303491"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2016.10.013","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Susceptibility to cephalosporin combinations and aztreonam\/avibactam among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2016.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}